Kinematics of Ewing Amputees

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

32 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-17

Study Completion Date

2026-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The agonist-antagonist myoneural interface (AMI) construct, known as the Ewing amputation at the trans-tibial level, has been shown to create a bi-directional neural communication platform as a means of controlling and interpreting proprioceptive feedback from a prosthetic joint. In AMI constructs, agonist-antagonist muscles are mechanically coupled within the residual limb, and volitional contraction of an agonist passively stretches that muscle's antagonist. The natural neural responses from muscle spindles within both muscles are then interpreted by the central nervous system as sensations of joint position and speed, associated with movement of the prosthesis.

The aim of this research protocol is to evaluate the electromyographic and kinematic patterns of participants who have undergone unilateral lower extremity Ewing Amputation in order to determine how similar their residual limb data is when compared to their intact limb data. A secondary aim of this research may include comparison of the Ewing participant cohort's biomechanical patterns to a similar cohort of participants who have undergone standard amputation.

The investigators hypothesize that the affected limb of patients with the Ewing procedure will demonstrate a pattern of electromyographic activation of their AMI constructs and kinematic data that recapitulates the pattern seen in their intact limb. The investigators secondarily hypothesize that the kinematic assessment of Ewing Amputation patients will demonstrate patterns that are significantly more physiologic than those witnessed in similar assessments of standard amputees.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Studying Electromyographic Activity in Patients With Upper Limb Amputations

NCT02956603

Amputation, Traumatic

COMPLETED NA

Assessment of Gesture Accuracy of a Prosthesis Control System

NCT06446037

Upper Limb Amputation Below Elbow (Injury)

COMPLETED EARLY_PHASE1

Pattern Recognition Prosthetic Control

NCT04272593

Prosthesis User Congenital Amputation of Upper Limb Amputation; Traumatic, Limb

COMPLETED NA

Pattern Recognition Prosthetic Control

NCT04272489

Prosthesis User Congenital Amputation of Upper Limb Amputation; Traumatic, Limb

COMPLETED NA

Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control

NCT07011420

Amputation Amputation, Traumatic Amputation, Congenital +3 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The specific aim of this research protocol is to evaluate the electromyographic and kinematic patterns of participants who have undergone unilateral lower extremity Ewing Amputation in order to determine how similar their residual limb data is when compared to their intact limb data. A secondary aim of this research may include comparison of the Ewing participant cohort's biomechanical patterns to a similar cohort of participants who have undergone standard amputation.

The investigators hypothesize that the affected limb of participants with the Ewing procedure will demonstrate a pattern of electromyographic activation of their AMI constructs and kinematic data that recapitulates the pattern seen in their intact limb. The investigators secondarily hypothesize that the kinematic assessment of Ewing Amputation participants will demonstrate patterns that are significantly more physiologic than those witnessed in similar assessments of standard amputees.

This will be a cross-sectional study with only one visit. A convenience sample of 16 participants who have previously undergone a lower extremity Ewing amputation will be recruited for the proposed study. Participants may subsequently be matched with up to 16 control participants who have previously undergone standard amputation procedures.

Participants will be assessed in a single session in the Motion Analysis Lab (MAL) at Spaulding Rehabilitation Hospital (SRH). Each visit will consist of the procedures described below and is expected to last about two and a half (2.5) hours.

The investigators will collect demographic data for each participant to help with the study population characterization. Such data will include questions about past medical and surgical history, height, weight, and prosthetic and functional history. In addition to self-reported data from the participant, the investigators may review the electronic medical record of any Mass General Brigham (MGB) participant in order to confirm demographic information.

Clinical tests may be conducted by the investigators to assess participant's lower extremities. Clinical tests may include functional examination of each participant's range of motion (ROM) and muscular strength for the lower extremities. Passive hip movements (flexion, abduction, adduction, internal and external rotation), knee flexion and extension, and ankle dorsiflexion and plantar flexion may be assessed with a goniometer if the joint is present for each limb.

Gait evaluations will be performed in the MAL during one session. Participants will be asked to change into shorts and a short-sleeved shirt (such articles of clothing can be provided by the lab if needed). Data will be gathered simultaneously with an electromyographic (EMG) system and a motion capture system. Both systems are part of SRH inventory and are routinely used in clinical care.

The spatio-temporal parameters, kinematic data and electromyographic data obtained from the Motion Capture System are the primary outcomes. As an exploratory analysis, the investigators will seek the possibility of assessing other items such as symmetry measurements and energy recovery as secondary outcomes.

Biomechanical data will be collected to study gait patterns. To ensure the accuracy of the biomechanical data, the investigators may gather additional data on the participant's gait patterns using a ten-camera motion analysis system (VICON) that is equipped with force plates (AMTI). To track participant movement, reflective markers will be attached using bio-adhesive tape to the participant's lower limbs and trunk based on anatomical landmarks (for example: second metatarsal head, center of calcaneus, lateral malleolus, lateral shank, distal lateral epicondyles, lateral thigh, anterior superior iliac spine, and the sacrum). Reflective markers may also be placed on the prosthesis to track its movement. The VICON system includes standard video cameras to record the session. The investigators will ask study participants permission to video record the gait trials and use the material for scientific presentations.

Electromyographic (EMG) data may be collected to study the characteristics of lower extremity muscle activation patterns during gait. The investigators will follow the Surface Electromyography for the Non-Invasive Assessment of Muscles (SENIAM) guidelines to place electrodes on several lower extremity muscles. Those may include the following: gastrocnemius, tibialis anterior, peroneal longus, rectus femoris, vastus lateralis, biceps femoris, or gluteus maximus. EMG electrodes will be attached using bio-adhesive double-sided tape and secured with Coban (self-adherent wrap) if needed. Portable ultrasonography may be used to localize muscles for proper electrode placement at this time. To ensure proper contact, the skin will be prepped for the electrodes; the area will be cleaned with alcohol swabs and shaved if necessary. Data from the electrodes will be gathered simultaneously with an acquisition system synchronized with the motion analysis system.

In the event that the surface EMG (sEMG) is not sufficiently robust to carry out the trials, the investigators will move to needle-based electrodes. If it is determined that needle-based electrodes are to be used to collect EMG data on the residual limb of a given participant, the amputee participant will meet with a clinician on the protocol with significant experience working with placement of electrodes in residual limb musculature. Since the musculature on the residual limb will be different for each participant, the participants will be instructed to make test contractions (e.g. ankle dorsiflexion or plantarflexion) to assist in localizing muscle sites. Sterile fine-wire electrodes will then be placed by the clinician on the protocol in each of the muscles of interest. The needles for electrode placement are 27-gauge needles. These needles are used acutely in the clinical space to insert the fine-wire electrodes into the muscles. The needles are then removed, leaving behind the fine-wire electrode. The fine-wire electrode is extremely fine, with a diameter of .051 mm. Because electrode placement is minimally invasive, this will occur at the gait lab.

Each participant will be asked to complete gross motor task assessing static and dynamic balance in their shoes and with the prosthetic device they typically wear for community ambulation. The participant will be asked to do this several times until 5-10 trials with good foot contacts onto the force plates are collected for each side (leg) of the body. There will be regular rest breaks during testing. At the end of the session, a trained study investigator will perform a brief visual check of the areas where the surface electrodes were in contact with the skin to assess these pressure areas. This will mark the end of the study procedures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lower Extremity Amputation Trans-Tibial Amputation Traumatic Lower Extremity Amputation Agonist-Antagonist Myoneural Interface

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ewing Amputees

Amputees who have previously undergone Agonist-Antagonist Myoneural Interface construction at the trans-tibial level

Modified Amputation

Intervention Type PROCEDURE

Modified amputation procedure

Standard Amputees

Amputees who have previously undergone trans-tibial level amputations without the construction of Agonist-Antagonist Myoneural Interfaces

Standard Amputation

Intervention Type PROCEDURE

Standard amputation procedure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Modified Amputation

Modified amputation procedure

Intervention Type PROCEDURE

Standard Amputation

Standard amputation procedure

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Unilateral lower extremity amputees
* Greater than 12 months post-amputation procedure
* Possession and use of a working prosthesis as determined by subject's ability to wear it for 8 hours daily
* A stable, well-fitting socket as indicated by no prosthetic modifications within the prior 14 days and no plans to modify it within the following 30 days
* Follow-up visit with their prosthetist within the past 3 months
* The ability to walk independently without an assistive device
* The ability to follow directions and communicate pain or discomfort

Exclusion Criteria

* Patients beyond the stated age restrictions will be excluded
* Patients who have any underlying neurologic, orthopedic, or cardiopulmonary impairment that affects their gait as assessed by the study clinician.
* Patients with any medical or functional limitations preventing them from ambulating safely and independently without an assistive device.
* Patients will be excluded who do not have a prosthesis

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No